Thank you for that further insight.
It would appear that the company is making little to no effort in stimulating market interest with a lot of information being cut and paste from old releases and subtle changes to dates etc.
They advise having produced a commercial volume of Flavocide in India ? What have they done with it? How was it distributed ? Are there multiple trials in progress ? How are they performing? Preliminary results? Any progress at all in entry to anyone of the potential markets they suggest will produce ongoing income from? What are the staff and Directors doing on a daily basis besides getting paid ? Surely shareholders should be kept constantly informed in a better manner than is currently the case or is what they release the best they have ?
Too many questions automatically come to mind raised by the inability of the company to effectively engage with share holders or market influencers.
Back under the bottom drawer !
Add to My Watchlist
What is My Watchlist?
